Human immunodeficiency virus pre-exposure prophylaxis awareness among people who inject drugs in Portland, Oregon.

Int J STD AIDS

Public Health Division, HIV/STD/TB Program, Oregon Health Authority, Portland, OR, USA.

Published: July 2023

Background: Pre-Exposure Prophylaxis (PrEP) to prevent transmission of human immunodeficiency virus (HIV) among people who inject drugs (PWID) has demonstrated efficacy yet awareness of PrEP among PWID is low.

Methods: 2018 National Behavioral Health Survey data from the Portland, Oregon metropolitan statistical area was analyzed with chi-squared tests and generalized linear models to determine correlates of PrEP awareness among PWID.

Results: 80% of the sample had at least one indication for PrEP and 15% of the sample was aware of PrEP. Factors associated with higher PrEP awareness were: higher education level (PR = 1.083, CI = 1.018-1.153, = .012), reporting transactional sex (PR = 1.154, CI = 1.019-1.307, = .024), and men who have sex with men reporting condomless sex (PR = 1.376, CI = 1.081-1.752, = .010). Lack of a usual source of care (PR = 0.884, CI = 0.824-0.949, < .001) was negatively associated with PrEP awareness.

Conclusions: Interventions to increase PrEP awareness need to target groups with particularly low awareness and be delivered in settings accessible to PWID.

Download full-text PDF

Source
http://dx.doi.org/10.1177/09564624231154302DOI Listing

Publication Analysis

Top Keywords

prep awareness
12
human immunodeficiency
8
immunodeficiency virus
8
pre-exposure prophylaxis
8
people inject
8
inject drugs
8
portland oregon
8
prep
8
awareness
6
virus pre-exposure
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!